Hay, Douglas W.P.
GlaxoSmithKline plc.,
United Kingdom
2025 Rank: 112416
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 1028 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112416 | 117428 |
| Total Cites | 5710 | 6365 |
| H-index | 37 | 40 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 180 | 190 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 1041 | 1157 |
| Number of Single+First+Last Authored Papers | 81 | 81 |
| Total Cites to Single+First+Last Authored Papers | 2555 | 2848 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4760 | 5113 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
10.29%
|
|
Hay, Douglas W.P.
GlaxoSmithKline, USA,
United States
2024 Rank: 105891
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 970 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105891 | 111665 |
| Total Cites | 5587 | 6215 |
| H-index | 37 | 40 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 175 | 183 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 1023 | 1130 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 2508 | 2786 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4656 | 5002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
10.10%
|
|
Hay, Douglas W.P.
GlaxoSmithKline, USA,
United States
2023 Rank: 96630
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 899 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96630 | 103054 |
| Total Cites | 5521 | 6146 |
| H-index | 37 | 40 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 174 | 182 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 1018 | 1125 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 2483 | 2761 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4594 | 4937 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
10.17%
|
|
Hay, Douglas W.P.
GlaxoSmithKline, USA,
United States
2022 Rank: 87301
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 810 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87301 | 90968 |
| Total Cites | 5411 | 6031 |
| H-index | 37 | 40 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 171 | 179 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 1007 | 1114 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 2450 | 2727 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4489 | 4828 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
10.28%
|
|
Hay, Douglas W.P.
GlaxoSmithKline, USA,
United States
2021 Rank: 87058
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 826 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 87058 | 90617 |
| Total Cites | 5080 | 5667 |
| H-index | 36 | 39 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 169 | 177 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 987 | 1091 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 2191 | 2441 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4263 | 4587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.24 |
| Self-Citation Percentage |
10.36%
|
|
Hay, Douglas W.P.
GlaxoSmithKline, USA,
United States
2020 Rank: 77989
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Respiratory System
Rank in SubField 1: 682 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77989 | 80575 |
| Total Cites | 4970 | 5551 |
| H-index | 36 | 39 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 169 | 177 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 979 | 1083 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 2166 | 2416 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4157 | 4475 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.24 |
| Self-Citation Percentage |
10.47%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.